Sign In
Buy BLFS
$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
BioLife Solutions to Acquire Stirling Ultracold in an All-Stock Merger
04:03pm, Monday, 22'nd Mar 2021
BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction
HRC vs. BLFS: Which Stock Is the Better Value Option?
12:53pm, Monday, 08'th Mar 2021
HRC vs. BLFS: Which Stock Is the Better Value Option?
Analysts Back a Turnaround at BioLife Solutions
07:00pm, Saturday, 27'th Feb 2021
BioLife Solutions shares opened higher before moving sharply lower Thursday despite a higher analyst price target.
HRC vs. BLFS: Which Stock Should Value Investors Buy Now?
12:53pm, Thursday, 18'th Feb 2021
HRC vs. BLFS: Which Stock Is the Better Value Option?
3 Soaring MedTech Stocks That Might Lose Ground in 2021
09:47am, Wednesday, 30'th Dec 2020
Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.
BioLife Solutions, Inc.'s (BLFS) CEO Michael Rice on Q3 2020 Results - Earnings Call Transcript
02:56am, Sunday, 08'th Nov 2020
BioLife Solutions, Inc.'s (BLFS) CEO Michael Rice on Q3 2020 Results - Earnings Call Transcript
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
11:05am, Saturday, 08'th Aug 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioLife Solutions
Oppenheimer Believes BioLife Solutions (NASDAQ: BLFS) Won't Stop Here - Markets
01:55am, Friday, 07'th Aug 2020
Oppenheimer analyst Suraj Kalia maintained a Buy rating on BioLife Solutions (BLFS – Research Report) yesterday and set a price
BioLife Solutions Announces Second Quarter 2020 Financial Results
08:05pm, Thursday, 06'th Aug 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Should You Buy BioLife (BLFS) Ahead of Earnings?
12:38pm, Wednesday, 05'th Aug 2020
BioLife (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
When Should You Buy BioLife Solutions, Inc. (NASDAQ:BLFS)?
01:33pm, Monday, 03'rd Aug 2020
While BioLife Solutions, Inc. (NASDAQ:BLFS) might not be the most widely known stock at the moment, it received a lot...
BioLife Solutions to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
09:45pm, Thursday, 30'th Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
BioLife Solutions (NASDAQ:BLFS) Stock Rating Upgraded by BidaskClub
05:38am, Sunday, 19'th Jul 2020
BidaskClub upgraded shares of BioLife Solutions (NASDAQ:BLFS) from a hold rating to a buy rating in a research note released on Wednesday morning, BidAskClub reports. Other equities analysts also rece
